Polyglutamine diseases: looking beyond the neurodegenerative universe.
作者信息
Mielcarek Michal, Isalan Mark
机构信息
Department of Life Sciences, Imperial College London, London, UK; Imperial College Centre for Synthetic Biology, Imperial College London, London, UK.
出版信息
Neural Regen Res. 2021 Jun;16(6):1186-1187. doi: 10.4103/1673-5374.300434.
Abstract
摘要
相似文献
1
Polyglutamine diseases: looking beyond the neurodegenerative universe.多聚谷氨酰胺疾病：超越神经退行性疾病范畴的探索
Neural Regen Res. 2021 Jun;16(6):1186-1187. doi: 10.4103/1673-5374.300434.
2
An Exploration of the Universe of Polyglutamine Structures.聚谷氨酰胺结构领域的探索
PLoS Comput Biol. 2015 Oct 23;11(10):e1004541. doi: 10.1371/journal.pcbi.1004541. eCollection 2015 Oct.
3
The pathogenic agent in Drosophila models of 'polyglutamine' diseases.果蝇“多聚谷氨酰胺”疾病模型中的病原体。
Hum Mol Genet. 2005 Apr 15;14(8):1041-8. doi: 10.1093/hmg/ddi096. Epub 2005 Mar 9.
4
Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases.多聚谷氨酰胺神经退行性疾病中错误折叠蛋白的细胞内降解
Brain Res Rev. 2008 Nov;59(1):245-52. doi: 10.1016/j.brainresrev.2008.08.003. Epub 2008 Aug 23.
5
Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal.病理性聚谷氨酰胺聚集始于自毒聚合物晶体。
Elife. 2023 Nov 3;12:RP86939. doi: 10.7554/eLife.86939.
6
Targeting protein aggregation in neurodegeneration--lessons from polyglutamine disorders.针对神经退行性疾病中的蛋白质聚集——来自多聚谷氨酰胺疾病的经验教训。
Expert Opin Ther Targets. 2006 Aug;10(4):505-13. doi: 10.1517/14728222.10.4.505.
7
microRNA dysregulation in polyglutamine toxicity of TATA-box binding protein is mediated through STAT1 in mouse neuronal cells.在小鼠神经元细胞中，TATA 盒结合蛋白的多聚谷氨酰胺毒性中的 microRNA 失调是通过 STAT1 介导的。
J Neuroinflammation. 2017 Aug 3;14(1):155. doi: 10.1186/s12974-017-0925-3.
8
Huntington's disease: revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases.亨廷顿舞蹈症：重新审视聚谷氨酰胺神经退行性疾病中的聚集假说
FEBS J. 2008 Sep;275(17):4252-62. doi: 10.1111/j.1742-4658.2008.06561.x. Epub 2008 Jul 15.
9
Expanded polyglutamine domain proteins bind neurofilament and alter the neurofilament network.扩展的聚谷氨酰胺结构域蛋白与神经丝结合并改变神经丝网络。
Exp Neurol. 1999 Feb;155(2):195-203. doi: 10.1006/exnr.1998.6991.
10
Protective effect of chaperones on polyglutamine diseases.伴侣蛋白对多聚谷氨酰胺疾病的保护作用。
Brain Res Bull. 2001;56(3-4):165-8. doi: 10.1016/s0361-9230(01)00593-7.
引用本文的文献
1
A minimal region of the HSP90AB1 promoter is suitable for ubiquitous expression in different somatic tissues with applicability for gene therapy.HSP90AB1启动子的一个最小区域适用于在不同体细胞组织中进行普遍表达，可用于基因治疗。
Front Mol Biosci. 2023 Apr 17;10:1175407. doi: 10.3389/fmolb.2023.1175407. eCollection 2023.
2
Structural Abnormalities of the Optic Nerve and Retina in Huntington's Disease Pre-Clinical and Clinical Settings.亨廷顿病临床前和临床环境中的视神经和视网膜结构异常。
Int J Mol Sci. 2022 May 13;23(10):5450. doi: 10.3390/ijms23105450.
3
Identification of the Transcriptional Biomarkers Panel Linked to Pathological Remodelling of the Eye Tissues in Various HD Mouse Models.在各种亨廷顿舞蹈症（HD）小鼠模型中与眼组织病理重塑相关的转录生物标志物面板的鉴定。
Cells. 2022 May 18;11(10):1675. doi: 10.3390/cells11101675.
本文引用的文献
1
Prevalence of Non-psychiatric Comorbidities in Pre-symptomatic and Symptomatic Huntington's Disease Gene Carriers in Poland.波兰症状前和有症状的亨廷顿舞蹈症基因携带者中非精神科合并症的患病率。
Front Med (Lausanne). 2020 Mar 11;7:79. doi: 10.3389/fmed.2020.00079. eCollection 2020.
2
Polyglutamine Repeats in Neurodegenerative Diseases.多聚谷氨酰胺重复在神经退行性疾病中的作用。
Annu Rev Pathol. 2019 Jan 24;14:1-27. doi: 10.1146/annurev-pathmechdis-012418-012857. Epub 2018 Aug 8.
3
Neuro-Cardio Mechanisms in Huntington's Disease and Other Neurodegenerative Disorders.亨廷顿舞蹈症及其他神经退行性疾病中的神经-心脏机制
Front Physiol. 2018 May 23;9:559. doi: 10.3389/fphys.2018.00559. eCollection 2018.
4
Beyond motor neurons: expanding the clinical spectrum in Kennedy's disease.超越运动神经元：扩张肯尼迪病的临床谱。
J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):808-812. doi: 10.1136/jnnp-2017-316961. Epub 2018 Jan 20.
5
Transcriptional Signature of an Altered Purine Metabolism in the Skeletal Muscle of a Huntington's Disease Mouse Model.亨廷顿舞蹈病小鼠模型骨骼肌中嘌呤代谢改变的转录特征
Front Physiol. 2017 Mar 2;8:127. doi: 10.3389/fphys.2017.00127. eCollection 2017.
6
An impaired metabolism of nucleotides underpins a novel mechanism of cardiac remodeling leading to Huntington's disease related cardiomyopathy.核苷酸代谢受损是导致亨廷顿舞蹈病相关心肌病的心脏重塑新机制的基础。
Biochim Biophys Acta. 2016 Nov;1862(11):2147-2157. doi: 10.1016/j.bbadis.2016.08.019. Epub 2016 Aug 26.
7
A shared mechanism of muscle wasting in cancer and Huntington's disease.癌症和亨廷顿舞蹈症中肌肉萎缩的共同机制。
Clin Transl Med. 2015 Dec;4(1):34. doi: 10.1186/s40169-015-0076-z. Epub 2015 Dec 14.
8
Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice.多聚谷氨酰胺重复序列过长导致SCA17小鼠肌肉退化。
Cell Rep. 2015 Oct 6;13(1):196-208. doi: 10.1016/j.celrep.2015.08.060. Epub 2015 Sep 17.
9
HDAC4-myogenin axis as an important marker of HD-related skeletal muscle atrophy.HDAC4-肌细胞生成素轴作为亨廷顿舞蹈病相关骨骼肌萎缩的重要标志物。
PLoS Genet. 2015 Mar 6;11(3):e1005021. doi: 10.1371/journal.pgen.1005021. eCollection 2015 Mar.
10
Skeletal muscle pathology in Huntington's disease.亨廷顿病的骨骼肌病理学。
Front Physiol. 2014 Oct 6;5:380. doi: 10.3389/fphys.2014.00380. eCollection 2014.
Zotero 插件